Stanley Almeida, a patient with delusional disorder, appealed a Consent and Capacity Board decision finding him incapable of consenting to or refusing treatment.
Dr. Andrew Morgan, his psychiatrist, brought a motion for an interim order to administer intravenous antipsychotic medication (Invega Sustenna) pending the appeal's resolution.
The court denied Almeida's adjournment request, citing urgency due to his deteriorating health and the unlikelihood of counsel being available quickly.
Applying the criteria under s. 19 of the Health Care Consent Act, the court found that the treatment would substantially improve Almeida's condition, benefits outweighed risks, it was the least restrictive option given his non-compliance, and it was necessary before the appeal.
The motion was granted, authorizing treatment until the appeal is resolved, and the appeal was expedited.